Quantcast

Latest Diabetes mellitus type 1 Stories

2014-09-22 23:11:54

NewYork-Presbyterian/Columbia University Medical Center, a national leader in diabetes care, is first in NY metro area to offer new procedure New York, NY (PRWEB) September 22, 2014 Video: Preventing Diabetes After Pancreatectomy - Dr. Beth Schrope NewYork-Presbyterian/Columbia University Medical Center now offers autologous islet cell transplantation, or auto islet surgery, to prevent diabetes in patients who require a total pancreatectomy. The hospital is the first center in the New...

2014-09-19 08:25:44

VIENNA, Austria, September 19, 2014 /PRNewswire/ -- Reductions in kidney failure obtained during intensive glucose control persist for many years in people with diabetes type 2 "Intensive treatment is likely to produce major long term benefits for the kidneys." Australian researchers have discovered that intensive glucose control in patients with type 2 diabetes leads to persistent...

2014-09-19 08:25:32

VIENNA, September 19, 2014 /PRNewswire/ -- Australian researchers have discovered that the reductions in heart events and death, from using blood pressure-lowering drugs in patients with type 2 diabetes, persist for many years after treatment has stopped. The global study has found that, six years after stopping intensive treatment with the combination of perindopril and indapamide, patients with type 2 diabetes continued to have a lower risk of serious heart disease...

2014-09-17 23:11:56

The Diabetes Protocol is a new product designed by Dr. Kenneth Pullman that reveals to people a highly advanced solution for treating diabetes for life. A detailed review on the site Vinamy.com indicates if this product is worth buying. Seattle, Wa (PRWEB) September 17, 2014 Diabetes currently has no cure. According to an article published by the Telegraph in August 2014, scientists made several breakthroughs in search for a “definite” cure for diabetes, but still failed. The article...

2014-09-16 08:31:56

--New Collaboration will Increase Data Available to Artificial Pancreas Researchers -- NEW YORK and SAN FRANCISCO, Sept. 16, 2014 /PRNewswire-USNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, and Tidepool (TM), a Silicon Valley-based non-profit organization committed to reducing the burden of T1D, announced a partnership supported by JDRF funding for data access technology for people with T1D who use insulin pumps and...

2014-09-16 08:30:07

ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche's ACCU-CHEK(®) Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents...

2014-09-16 08:29:35

MERIDEN, Conn. and STOCKHOLM, Sept. 16, 2014 /PRNewswire/ -- Protein Sciences Corporation and Diamyd Medical AB announced today that Protein Sciences has broadened its commitment to diabetes and become a strategic and significant shareholder in Diamyd Medical, its long-time partner in this domain. Protein Sciences will manufacture product for upcoming late stage clinical trials for type 1 diabetes involving Diamyd Medical's recombinant GAD (glutamic acid decarboxylase) protein made...

2014-09-10 16:26:29

SAN DIEGO, Sept. 10, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a stem cell-derived islet replacement therapy for the treatment of diabetes, called VC-01, announced today that it has been selected to receive a $16.6 million Accelerated Development Pathway Award from the California Institute for Regenerative Medicine (CIRM). According to CIRM, the Accelerated Development Awards were created to "provide selected applicants who are...

2014-09-10 08:29:58

ROSH HA-AYIN, Israel, September 10, 2014 /PRNewswire/ -- Beta-O2 announced today that it has received a $500K grant from JDRF. The grant will be used to help fund a $1M pilot human study of Beta-O2's ssAir bio-artificial pancreas, in development as a treatment and potential cure for type 1 diabetes (T1D). The two-year study, which will enroll eight participants at Uppsala University Hospital in Sweden, will evaluate the safety, survival and function of implanted human islets...

2014-09-08 08:26:41

Can diabetes be reversed? This medical mystery has now been solved by medical researchers with a simple 3-step diet plan MIAMI, Sept. 8, 2014 /PRNewswire/ -- Nearly 40% of American adults will develop and be diagnosed with Diabetes Type II. Diabetes is one disease from a larger group of known metabolic diseases. With Diabetes, high blood sugar levels continue over a prolonged period of time and may cause complications such as Stroke, Heart Disease, Blindness, and Kidney Failure....


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related